GGrantIndex
Sort

130,381 grants matching hiv

NIAID - VRC - Pre-Clinical Assessment of monoclonal antibodies and other promising vaccines/agents

$2,198,288
Christopher Case · Leidos Biomedical Research, Inc. · N01 · FY2022 · AI

Mechanisms of Immune Activation and Disease Progression in Animal Models

$2,198,016
Jason Brenchley · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Project 1 - Development of mRNA Immunogens for Protective Antibody Induction

$2,197,512
Barton F Haynes · Duke University · U19 · FY2022 · AI

HIV persistence in vivo

$2,196,968
Eli Boritz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LAB AIDS VACCINE R&D

$2,196,301
David C Montefiori · Duke University · N01 · FY2014 · AI

Studies in humans to delineate the basis for viral persistence

$2,195,844
David M. Margolis · Univ Of North Carolina Chapel Hill · U19 · FY2013 · AI

Center for AIDS Intervention Research Core Support

$2,195,681
Jeffrey A. Kelly · Medical College Of Wisconsin · P30 · FY2010 · MH

PROVISION OF MEDICAL MALE CIRCUMCISION (MMC) FOR HIV PREVENTION IN KWAZULU NATAL

$2,195,328
Colleen Khumalo · Sactwu Aids Project · U2G · FY2015 · GH

Functional Testing of Host Genes that control HIV Latency in Primary Immune Cells

$2,195,087
Alexander Marson · University Of California, San Francisco · DP2 · FY2016 · DA

HIV Susceptibility and Pathogenesis in the Female Genital Tract

$2,194,484
Alan L Landay · Rush University Medical Center · P01 · FY2010 · AI

East Africa IeDEA Regional Consortium

$2,193,908
Kara Kay Wools-Kaloustian · Indiana University Indianapolis · U01 · FY2015 · AI

Center for Translational Viral Oncology (CTVO)

$2,193,720
John T. West · Lsu Health Sciences Center · P20 · FY2022 · GM

Center on Antisocial Drug Dependence: The Genetics of HIV Risk Behaviors

$2,193,298
John K Hewitt · University Of Colorado · P60 · FY2012 · DA

Enhanced Access to HIV Care for Drug Users in San Juan, Puerto Rico

$2,192,440
Lisa R Metsch · Columbia University Health Sciences · R01 · FY2016 · DA

Primate Lentivirus Pathogenesis

$2,191,018
Malcolm Martin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI

Non-Human Primate Discovery Team

$2,190,977
Norman L Letvin · Duke University · U19 · FY2011 · AI

Third Coast Center for AIDS Research

$2,189,210
Richard T D'aquila · Northwestern University At Chicago · P30 · FY2018 · AI

Assay development and screening for molecular targets and discovery

$2,189,067
Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Targeting Immunogenicity to the MPER Hinge and C-helix for BNAb Elicitation

$2,189,065
Ellis L Reinherz · Dana-Farber Cancer Inst · P01 · FY2018 · AI

The Johns Hopkins University - Uganda Clinical Trials Unit

$2,188,828
Mary Glenn Fowler · Johns Hopkins University · UM1 · FY2022 · AI

Clinical and Translational Science Coordinating Center

$2,188,132
Gordon R. Bernard · Vanderbilt University · U54 · FY2015 · TR

Women's Interagency HIV Study (WIHS-V)

$2,187,948
Kathryn M Anastos · Albert Einstein College Of Medicine · U01 · FY2015 · AI

CENTER OF EXCELLENCE FOR COMPREHENSIVE INTEGRATED HIV Care MALAWI

$2,187,326
Sam Jp Phiri · Lighthouse Trust · U2G · FY2014 · GH

A randomized clinical trial of client-centered care coordination to improve pre-exposure prophylaxis use for Black men who have sex with men

$2,187,174
Darren Lovell Whitfield · University Of Maryland Baltimore · RF1 · FY2025 · MH

HIV Vaccine Design and Development Teams, Part A- Preventative Vaccines

$2,186,845
Novartis Vaccines And Diagnostics, Inc. · N01 · FY2013 · AI